Britannia Life Sciences Inc. (CNSX:BLAB) entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited on April 7, 2022. Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary. Gowling WLG (UK) LLP and Bennett Jones LLP acted as legal advisor to Britannia Life Sciences Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -33.33% | -33.33% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 5.94M | |
+17.10% | 8.43B | |
+14.30% | 6.82B | |
-3.69% | 3.77B | |
-7.34% | 3.74B | |
+1.78% | 1.44B | |
-28.77% | 1.06B | |
+18.84% | 1.04B | |
-11.81% | 890M | |
-18.34% | 812M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited.